EP/EC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EP/EC, covering 2022-12-30 to 2022-12-30. Get the full timeline:
Most recent: Clinical Trial Update: Surufatinib in Combination of Durvalumab and EP/EC in the Firstly-line Treatment of ES-SCLC [Phase 2]